Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022-Reference-Cited by-同舟云学术

Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022

Published:2023-05-01 Issue:5 Volume:30 Page:531-557
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Harada-Shiba Mariko¹,Ohtake Akira²,Sugiyama Daisuke³,Tada Hayato⁴,Dobashi Kazushige⁵,Matsuki Kota⁶,Minamino Tetsuo⁷,Yamashita Shizuya⁸,Yamamoto Yukiyo⁹

Affiliation:

1. Cardiovascular Center, Osaka Medical and Pharmaceutical University

2. Department of Pediatrics, Faculty of Medicine, Saitama Medical University

3. Faculty of Nursing and Medical Care, Keio University

4. Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine

5. Department of Pediatrics, School of Medicine, University of Yamanashi

6. Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine

7. Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University

8. Department of Cardiology, Rinku General Medical Center

9. Department of Medical Education, Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Japan

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/30/5/30_CR006/_pdf

Reference95 articles.

1. 1) Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS: Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. Jama, 2003; 290: 2271-2276

2. 2) Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb, 1993; 13: 1291-1298

3. 3) Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, Yamashita S, Yokote K: Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb, 2018; 25: 539-553

4. 4) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407

5. 5) Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, Tu JV: Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open, 2017; 7: e016461

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review;Nutrients;2024-09-01

2. Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?;Current Atherosclerosis Reports;2024-08-27

3. Japanese Diagnostic Criteria for Pediatric Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2024-07-01

4. Improved Efficiency of the Clinical Diagnostic Criteria for Familial Hypercholesterolemia in Children: A Comparison of the Japan Atherosclerosis Society Guidelines of 2017 and 2022;Journal of Atherosclerosis and Thrombosis;2024-07-01

5. Validation of physical examinations of tendon xanthomas and changes in the cutoff values of Achilles tendon thickness on radiography in the clinical criteria of heterozygous familial hypercholesterolemia in Japan;Journal of Clinical Lipidology;2024-07